Using these novel models, we analyzed bulk TCRβ and scRNA+TCRαβ-seq datasets from AML, CML, and MDS patients to quantify WT1-specific T-cell frequencies and phenotypic characteristics. This evidence concerns the gene WT1 and chronic myelogenous leukemia, BCR-ABL1 positive.